Companies: 10,795·Total market cap: $144.5T

Kazia Therapeutics Limited

Kazia Therapeutics Limited

KZIANASDAQHealthcare● Active

$11.40

+$0.41(+3.73%)

Market Cap$18465617

P/E Ratio—

52W High$17.4

52W Low$4.86

Avg Volume210K

Open$11.89

Beta2.18

股票排行：Biotechnology·Healthcare·查看全部市值排行 →

Kazia Therapeutics Limited（KZIA）股票概览

关键指标与盈利、估值、营收、股息等标签页深链。

FMP · KZIA · 截至 Jun 9, 2026

关键指标

EPS (TTM)$-47.70Earnings history

PE Ratio (TTM)—PE Ratio deep dive

Revenue (TTM)$2.5MFull revenue history

Dividend Yield不分红Dividend history

Shares Outstanding1.1MShares outstanding history

Next EarningsSep 4, 2026Est.Earnings history

探索 Kazia Therapeutics Limited 数据

分析师预测$22 · Buy

股息不分红

营收$42000-98.18%

盈利EPS $-18.90+65.64%

财务快照

FY 2025Revenue$42000.00▼ 98.18% YoY

202320242025

FY 2025Net Income-$20.7M▲ +22.69% YoY

202320242025

FY 2025EPS$-18.90▲ +65.64% YoY

202320242025

TTM:Revenue: $2.5MNet Income: -$50.7MEPS: $-47.70View income statement →

分析师评级与目标价

Buy2 位分析师

Strong Buy

0

Buy

2

Hold

0

Sell

0

Strong Sell

0

12-Month Price Target

$18.00Low

$11.40Current

$21.50Avg Target上涨空间 88.60%

$25.00High

合计: 2 · 买入占比: 100.0%

根据过去 3 个月内 2 位华尔街分析师，KZIA 共识评级为 Buy，12 个月平均目标价 $21.50 （较现价 $11.40 上涨空间 88.60%）。

竞争对手与同行

#TickerCompanyPriceChangeMkt Cap

Kazia Therapeutics Limited

$11.40+3.73%$18.5M #2

Biodexa Pharmaceuticals Plc

$3.26-2.98%$54,688.89 #3

Can-Fite BioPharma Ltd.

$3.08-0.32%$2.6M #4

Clearmind Medicine Inc.

$3.79-4.77%$3.9M #5

CNS Pharmaceuticals, Inc.

$4.89-2.20%$2.8M #6

$2.17+8.50%$194,935

股票表现

1D+3.73%

1W-2.56%

1M-21.05%

3M+38.18%

YTD+65.46%

1Y+115.09%

5Y-97.77%

关于 Kazia Therapeutics Limited

CEOJohn Edwin Friend

IPO DateJan 6, 1999

Employees9

CountryAU

Websitekaziatherapeutics.com

Kazia Therapeutics Limited is a biotechnology firm primarily dedicated to creating pharmaceutical treatments for cancer. Its leading therapeutic asset is Paxalisib, a distinctive small molecule that c…

Biotechnology HealthcareNASDAQADRAU

关于股票概览与关键数据

Kazia Therapeutics Limited（KZIA）是 Biotechnology 行业的 Healthcare 类公司，于 Jan 6, 1999 在 NASDAQ 上市。截至最近交易日，KZIA 股价为 $11.40，市值约为 $18.5M。过去12个月累计回报 +115.09%，年初至今回报 +65.46%。

根据 2 位华尔街分析师，Kazia Therapeutics Limited 股票共识评级为Buy，12个月平均目标价为 $21.50。2025 财年 Kazia Therapeutics Limited 营收 $42000.00，净利润 -$20.7M。更多数据（营收历史、盈利、股息、市盈率）请使用上方标签页。

常见问题

截至最近一个交易日，Kazia Therapeutics Limited（KZIA）股价为 $11.40，在 NASDAQ 上市，52周区间为 $4.86 – $17.40。

KZIA 最新股价KZIA quote todaylive ticker 实时行情

数据来源：Financial Modeling Prep最后更新：Jun 9, 2026本内容不构成投资建议